(Q74796242)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

C Faught

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

P Wells

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

D Fergusson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

A Laupacis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

Transfusion Medicine Reviews

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

206-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators.

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Efficacy of hemostatic agents in improving surgical hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

1 reference

7 January 2021

High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin in staged heart transplantation: anaphylactic potential of repeated exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Anaphylactic shock after aprotinin reexposure: time course of aprotinin-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application--clinical experience in 152 cardiac surgical patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The Impact of Aprotinin on Coronary Artery Bypass Graft Patency

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

High-dose aprotinin in cardiac surgery--a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin in aortic surgery requiring profound hypothermia and circulatory arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Intraoperative coronary thrombosis: can aprotinin and protamine be incriminated?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Effects of minimal-dose aprotinin on coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Rhabdomyolysis induced by epsilon-aminocaproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Cerebral Thrombosis Associated with Amicar Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Thrombosis with epsilon aminocaproic acid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Microscopic haematuria as a relative contraindication for tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The dose-response relationship of tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Prophylactic treatment of postperfusion bleeding using EACA.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Changes in Blood Coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Reduction of Postprostatectomy Bleeding by Epsilon-Aminocaproic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aminocaproic acid in the control of haemorrhage after prostatectomy. Safety of aminocaproic acid--a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Complications of Antifibrinolysis Therapy after Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The effect of epsilon aminocaproic acid on the blood loss after retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The effect of the fibrinolytic inhibitor epsilonaminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Prostatectomy and Deep-Vein Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Thromboembolic complications following radical retropubic prostatectomy. Influence of external sequential pneumatic compression devices

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Infusion rate and hemodynamics with desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Hemodynamic responses to desmopressin acetate after CABG: a double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Hemodynamic performance and histamine levels after desmopressin acetate administration following cardiopulmonary bypass in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double-blinded, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Thrombosis following desmopressin for uremic bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Cholecystokinin and glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Lamotrigine versus carbamazepine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Desmopressin and blood loss after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Chairman's Workshop Report: Hypertension and cardiovascular effects--long-term safety and potential long-term benefits of r-HuEPO

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Subcutaneous use of erythropoietin in heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Utilization and effectiveness of a hospital autologous preoperative blood donor program

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Moderate and severe reactions during autologous blood donations are no more frequent than during homologous blood donations

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The safety of preoperative autologous blood donation in the nonhospital setting

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Donation reactions among autologous donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Severe outcomes of allogeneic and autologous blood donation: frequency and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Comparable safety of blood collection in "high-risk" autologous donors versus non-high-risk autologous and directed donors in a hospital setting

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Predonated autologous blood use in elective cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Impact of autologous blood predonation on a comprehensive blood conservation program.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Determinants for early mortality in patients awaiting coronary artery bypass graft surgery: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

1 reference

7 January 2021

Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Predonation autologous blood in hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Autologous transfusion-transmitted Yersinia enterocolitica

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Transfusion-transmitted Serratia liquifaciens from an autologous blood unit

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Yersinia enterocolitica septicemia in autologous blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Septic shock due to Yersinia enterocolitica after autologous transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

A report of 104 transfusion errors in New York State

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Autologous donation error rates in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: pro.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Intraoperative blood salvage: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Intraoperative autotransfusion in aortic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Adverse effects of postoperative infusion of shed mediastinal blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Coagulopathy after reinfusion of autologous scavenged red blood cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Disseminated intravascular coagulation after aortic aneurysm repair, intraoperative salvage autotransfusion, and aprotinin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Is the "salvaged-cell syndrome" myth or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Coagulopathy complicating intraoperative blood salvage in a patient who had idiopathic scoliosis. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Autologous blood transfusion for major vascular surgery using the Sorenson Receptal Device.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Autotransfusion--bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis. A randomized controlled study of 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Incidence of Cell-Saver contamination during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Separation of malignant cells during autotransfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Intraoperative autotransfusion in urologic oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Upper airway oedema following autologous blood transfusion from a wound drainage system

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Glove powder introduced in the circulation by autotransfusion and severe cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Perioperative blood transfusion and outcome after resection for colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980061-8

7 January 2021

10.1016/S0887-7963(98)80061-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9673005%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference